This chemical is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various biologically active compounds. Its structure, featuring both piperazine and piperidine moieties, makes it a valuable building block for the development of drugs targeting the central nervous system. It is often employed in the creation of potential therapeutic agents for neurological disorders, such as schizophrenia, depression, and anxiety, due to its ability to interact with neurotransmitter receptors. Additionally, its tert-butyl carboxylate group enhances stability and solubility, making it suitable for further chemical modifications in drug discovery and development processes.